Correlation Between Adaptive Biotechnologies and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Crispr Therapeutics AG, you can compare the effects of market volatilities on Adaptive Biotechnologies and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Crispr Therapeutics.
Diversification Opportunities for Adaptive Biotechnologies and Crispr Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptive and Crispr is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Adaptive Biotechnologies and Crispr Therapeutics
Given the investment horizon of 90 days Adaptive Biotechnologies is expected to generate 1.58 times less return on investment than Crispr Therapeutics. In addition to that, Adaptive Biotechnologies is 1.38 times more volatile than Crispr Therapeutics AG. It trades about 0.01 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.02 per unit of volatility. If you would invest 4,899 in Crispr Therapeutics AG on August 30, 2024 and sell it today you would earn a total of 185.00 from holding Crispr Therapeutics AG or generate 3.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptive Biotechnologies Corp vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Adaptive Biotechnologies |
| Crispr Therapeutics |
Adaptive Biotechnologies and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptive Biotechnologies and Crispr Therapeutics
The main advantage of trading using opposite Adaptive Biotechnologies and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets |